Pyrimidine derivatives for labeled binding partners
Compounds having structure (1) wherein R 1 is —H a protecting group, a linker or a binding partner; and R 2 and R 34 are as defined in the specification. The invention also provides intermediates and methods make the structure (1) compounds, as well as methods to use the compounds as labels in diagnostic assays and to enhance binding to complementary bases.
1. A pair of primers for amplification or detection of a nucleic acid, at least one of said primers comprising a compound of the formula B x —R 1 , or a tautomer, solvate or salt thereof, wherein R 1 is a binding partner and B x is of the subformula:
wherein
R 2 is A(Z) X1 , wherein A is a spacer and Z independently is a label bonding group optionally bonded to a detectable label, but R 2 is not an amine, protected amine, nitro or cyano; each
R 27 is independently —CH═, —N═, —C(C 1-8 alkyl)= or —C(halogen)=, but no adjacent R 27 are both —N═, or two adjacent R 27 are taken together to form a ring having the structure:
where R a is independently —CH, —N═, —C(C 1-8 alkyl)= or —C(halogen)=, but no adjacent R a are both —N═; and
R 34 is —O—, —S—, or —N(CH 3 )—; and X1 is 1, 2 or 3.
2. The pair of primers of claim 1 , wherein R 1 is an oligomer.
3. The pair of primers of claim 1 , wherein R 1 is a polymer.
4. The pair of primers of claim 1 , wherein R 1 is an oligonucleotide.
5. The pair of primers of claim 1 , wherein B x is a cytosine surrogate for supplemental Watson-Crick base pairing.
6. The pair of primers of claim 1 , wherein Z is capable of hydrogen bonding to a guanine in a complementary oligonucleotide strand.
7. The pair of primers of claim 1 , wherein Z is bonded to a detectable label.
8. A pair of primers for amplification or detection of nucleic acid, each of said pair of primers comprising a compound of the formula B x —R 1 , or a tautomer, solvate or salt thereof, wherein R 1 is a binding partner and B x is of the subformula:
wherein
R 2 is A(Z) X1 , wherein A is a spacer and Z independently is a label bonding group optionally bonded to a detectable label, but R 2 is not an amine, protected amine, nitro or cyano; each
R 27 is independently —CH═, —N═, —C(C 1-8 alkyl)= or —C(halogen)=, but no adjacent R 27 are both —N═, or two adjacent R 27 are taken together to form a ring having the structure:
where R a is independently —CH═, —N═, —C(C 1-8 alkyl)= or —C(halogen)=, but no adjacent R a are both —N═; and
R 34 is —O—, —S—, or —N(CH 3 )—; and X1 is 1, 2 or 3.
9. The pair of primers of claim 8 , wherein R 1 is an oligomer.
10. The pair of primers of claim 8 , wherein R 1 is a polymer.
11. The pair of primers of claim 8 , wherein R 1 is an oligonucleotide.
12. The pair of primers of claim 8 , wherein B x is a cytosine surrogate for supplemental Watson-Crick base pairing.
13. The pair of primers of claim 8 , wherein Z is capable of hydrogen bonding to a guanine in a complementary oligonucleotide strand.
14. The pair of primers of claim 8 , wherein Z is bonded to a detectable label.
15. A method for amplification of nucleic acid, the method comprising:
selecting at least one primer for use in said method, the primer comprising a compound of the formula B x —R 1 , or a tautomer, solvate or salt thereof, wherein R 1 is a binding partner and B x is of the subformula:
wherein
R 2 is A(Z) X1 , wherein A is a spacer and Z independently is a label bonding group optionally bonded to a detectable label, but R 2 is not an amine, protected amine, nitro or cyano; each
R 27 is independently —CH═, —N═, —C(C 1-8 alkyl)= or —C(halogen)=, but no adjacent R 27 are both —N═, or two adjacent R 27 are taken together to form a ring having the structure:
where R a is independently —CH═, —N═, —C(C 1-8 alkyl)= or —C(halogen)=, but no adjacent R a are both —N═; and
R 34 is —O—, —S—, or —N(CH 3 )—; and X1 is 1, 2 or 3; and
performing at least one step for amplifying or detecting a nucleic acid sequence.
16. The method of claim 15 , wherein R 1 is an oligomer.
17. The method of claim 15 , wherein R 1 is a polymer.
18. The method of claim 15 , wherein R 1 is an oligonucleotide.
19. The method of claim 15 , wherein B x is a cytosine surrogate for supplemental Watson-Crick base pairing.
20. The method of claim 15 , wherein Z is capable of hydrogen binding to a guanine in a complementary oligonucleotide strand.
21. The method of claim 15 , wherein Z is bonded to a detectable label.
22. The method of claim 15 , wherein said primer is a member of a set of primers, and both members of the set of primers are independently of the formula B x—R 1 , or a tautomer, solvate or salt thereof, wherein R 1 is a binding partner and B x is of the subformula:
wherein the variables are as defined in claim 15 .